Dermatologicals represent a significant and growing portion of workers’ comp spend and come with cost and efficacy considerations.

An infographic breakdown of the diverse drug categories that comprise dermatological prescribing and spend.

A new report from the CWCI highlights trends in dermatologicals, opioids, and antidepressants.

With opioid utilization down, there is no longer a consolidated driver of pharmacy costs in workers’ comp. Here are four drug classes driving pharmacy costs today.

As opioid prescribing continues to decline, more nuanced and population-specific drug trends emerge as cost drivers.

WCRI explores how drug payments varied across 28 states for key drug therapy groups.